Biotech Exit: Million Arcellx Sparks Investor Reassessment
A notable stake sale in Arcellx turned heads in biotech investing. This article unpack the $26 million exit, why the ...
Ways To Cope With Unexpected Personal Finance Challenges
Coping with unexpected personal finance challenges involves rapid assessment, prioritizing essentials, and building a short-term recovery plan you can follow.
15,854 articles
Trump Will Longer Able: Supreme Court Upends Tariffs This Year
The Supreme Court ruled that broad emergency tariffs under IEEPA were unlawful, a decision that curbs presidential po...
Warren Buffett, Last Quarter Move Investors Shouldn't Ignore
As Warren Buffett closes one chapter, a decisive last quarter move offers a powerful lesson in patience, discipline, ...
Reasons Berkshire Hathaway Stock: Two Compelling Bets
Two compelling reasons berkshire hathaway stock could shine in any market. This piece breaks down the moat, cash flow...
Movers: Trade Desk Surges as Markets Digest Fed Bets
The Trade Desk surged after a large insider purchase by its CEO, lifting the stock among S&P 500 movers as Palantir a...
Investor Buys Million Enviri as Stock Surges 100% in a Year
A large institutional stake in Enviri sparks questions about the company’s trajectory. This article breaks down what ...
Top 2 Consumer Staples Stocks Right Now for Steady Gains
Facing market volatility, savvy investors turn to durable brands. Here are two consumer staples stocks right now that...
Calydon Capital Dumps Million: ZoomInfo Stock Decline Deepens
A major hedge fund trimmed its ZoomInfo position by millions, fueling questions about the company's prospects. This a...
Undervalued Stock Investors Amid Decline: How to Thrive Now
When markets slide, value-minded investors can find hedges and growth tucked into solid fundamentals. Learn a simple,...
Former Trump Advisor: ‘Conservatives’ Threaten R&D Boom
A new policy debate threatens to tax the income universities earn from licensing taxpayer-funded research, potentiall...
This Fund Sold Klaviyo Before a 32% Post-Earnings Drop
A single fund's exit from Klaviyo set off a ripple effect that shaved a chunk from the stock after earnings. This art...
Why This Biotech Fund Increased Its Oruka Stake Amid a 500% Rally
A biotech fund just boosted its Oruka Therapeutics position after a blistering rally. Here’s what the move signals ab...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status